SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-124872
Filing Date
2018-04-20
Accepted
2018-04-20 16:07:03
Documents
5
Period of Report
2018-05-31
Effectiveness Date
2018-04-20

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d489722ddef14a.htm DEF 14A 363137
2 GRAPHIC g489722g52i13.jpg GRAPHIC 33700
3 GRAPHIC g489722g78c30.jpg GRAPHIC 35103
4 GRAPHIC g489722pc1.jpg GRAPHIC 214065
5 GRAPHIC g489722pc2.jpg GRAPHIC 194225
  Complete submission text file 0001193125-18-124872.txt   1002153
Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36579 | Film No.: 18766732
SIC: 2836 Biological Products, (No Diagnostic Substances)